Accession Number: | 0001209191-21-017941 |
Date: | 2021-03-02 |
Issuer: | SYNEOS HEALTH, INC. (SYNH) |
Original Submission Date: |
MACDONALD ALISTAIR
C/O SYNEOS HEALTH, INC.
1030 SYNC STREET
MORRISVILLE, NC 27560
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
CLASS A COMMON STOCK | 2021-03-02 | A | 7,993 | a | $0.00 | 205,586 | direct | ||
CLASS A COMMON STOCK | 2021-03-02 | A | 4,308 | a | $0.00 | 209,894 | direct | ||
CLASS A COMMON STOCK | 2021-03-02 | F | 14,692 | d | $75.50 | 195,202 | direct | ||
CLASS A COMMON STOCK | 2021-03-02 | M | 36,429 | a | $0.00 | 231,631 | direct | ||
CLASS A COMMON STOCK | 2021-03-02 | F | 17,122 | d | $75.50 | 214,509 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
PERFORMANCE RESTRICTED STOCK UNITS | 0.0 | 2021-03-02 | deemed execution date | M | 36,429 (d) | class a common stock 36,429 | $0.00 | 0 | direct |
ID | footnote |
---|---|
f1 | represents performance restricted stock units that were earned based upon performance criteria for the year ended december 31, 2020 and will vest in full once the compensation and management development committee (the "committee") of the board of directors of syneos health, inc. determines the attainment level of the performance goals for the year ended december 31, 2021, subject to continued employment. |
f2 | represents performance restricted stock units that were earned based upon performance criteria for the year ended december 31, 2020 and will vest in full once the committee determines the attainment level of the performance goals for the year ended december 31, 2022, subject to continued employment. |
f3 | represents performance restricted stock units that were earned based upon the achievement of $100 million of defined synergy savings on an annual run-rate through december 31, 2020, as determined by the committee on march 2, 2021. |